Indaptus Therapeutics, Inc.

NASDAQ:INDP

Biotechnology

Healthcare
$3.32 -2.21%

-$0.03 today

Market cap
$375.96M
Beta
1.14
P/E (TTM)
-0.2
EPS (TTM)
-$8.70
52W Low $0.92High $8.69

Volume 0.28M

Average 0.97M

Price history

Indaptus Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+43.72%

Period high

$4.75

Period low

$0.94

Latest

$3.32

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 13, 2026Nov 13, 2026
8-KNov 13, 2026Nov 13, 2026
SC 13D/AOct 22, 2026Oct 22, 2026
SC 13D/AOct 22, 2026Oct 22, 2026
SC 13D/AOct 22, 2026Oct 22, 2026
SC 13D/AOct 21, 2026Oct 21, 2026
8-KOct 20, 2026Oct 20, 2026
S-8Oct 5, 2026Oct 5, 2026
8-KSep 30, 2026Sep 30, 2026
8-KSep 10, 2026Sep 9, 2026
8-K/ASep 8, 2026Sep 4, 2026
424B5Sep 4, 2026Sep 4, 2026
8-KSep 4, 2026Sep 4, 2026
8-KSep 1, 2026Sep 1, 2026
424B5Aug 31, 2026Aug 31, 2026

Competitors

Who does Indaptus Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Competitors

Peer companies in the same sector

Health

Questions

Filing questions

Common questions about INDP's filings, answered from its disclosures.

What is the latest INDP filing?

The latest filing shown is 8-K dated Nov 13, 2026.

How many recent filings does INDP have?

Intrinsic Alpha currently shows 20 recent filings for INDP.